CHARNWOOD MOLECULAR
Charnwood Molecular providing medicinal and synthetic chemistry services to the global pharmaceutical, biotechnology and chemical industries. The cornerstone of our success is regular and open communication with our clients, the highest integrity in our business relationships, high quality yet cost-effective services, and the flexibility that we offer to always meet our clients’ demands – we can undertake projects from one week in duration to multi-year, multi-FTE collaborations.
CHARNWOOD MOLECULAR
Industry:
Biotechnology
Founded:
1998-01-01
Address:
Loughborough, Leicestershire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.charnwood-molecular.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 1509 232007
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Apache Sitelinks Search Box
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-21 | Aurelia Bioscience | Aurelia Bioscience acquired by Charnwood Molecular | N/A |
Official Site Inspections
http://www.charnwood-molecular.com Semrush global rank: 4.09 M Semrush visits lastest month: 2.98 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Charnwood Molecular"
Charnwood Discovery the New Name for Charnwood …
Sep 20, 2023 Charnwood Molecular, a leading drug discovery CRO that specializes in enhancing the experience and success of complex drug discovery for clients globally, is excited to announce a significant milestone in its history. …See details»
Charnwood Molecular’s journey from university spin …
Oct 12, 2021 Steve Allin co-founded Charnwood Molecular with Phil Page in 1998. 22 years later, the business has evolved dramatically from its origins as a spinout of Loughborough University. Backed by a partnership with Synova …See details»
Charnwood Molecular Ltd Announces Rebrand to Charnwood …
Sep 25, 2023 Charnwood Molecular, a leading drug discovery CRO that specializes in enhancing the experience and success of complex drug discovery for clients globally, is …See details»
Charnwood Molecular unveils plans to quadruple capacity
Synova portfolio company, Charnwood Molecular, a leading UK-based outsourced drug discovery CRO servicing the global pharmaceutical and biotechnology market, has announced a …See details»
Charnwood Molecular - Crunchbase Company Profile & Funding
Charnwood Molecular providing medicinal and synthetic chemistry services to the global pharmaceutical, biotechnology and chemical industries. The cornerstone of our success is …See details»
CCD Partners advises Charnwood Molecular on …
Jan 22, 2020 Steve Allin co-founded Charnwood Molecular with Phil Page in 1998. 22 years later, the business has evolved dramatically from its origins as a spinout of Loughborough University. Backed by a partnership with Synova …See details»
Charnwood Molecular - Craft
Charnwood Molecular is a contract research organization providing medicinal and synthetic chemistry services. Its offerings include medicinal chemistry, process research and chemical …See details»
Lee Patterson Appointed as New CEO of Charnwood Molecular
Jul 6, 2022 After nearly 25 years at Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, Prof. Steve Allin …See details»
UK-based CRO Charnwood Molecular reveals plans for ‘significant ...
Apr 29, 2021 The expansion plans include Charnwood Molecular becoming the sole occupier of a ‘state-of-the-art’ laboratory facility at Charnwood Campus, based in Loughborough. This …See details»
A quick look back at our history - LinkedIn
May 12, 2022 Founder and CEO of Charnwood Molecular, Steve Allin, commented: “The truly world-class facilities at Charnwood Campus provide us with a key piece in our strategic plan to become the provider of ...See details»
Charnwood Molecular chooses Charnwood Campus to …
Apr 28, 2021 Charnwood Molecular’s ambitious growth plans now see the company becoming the sole occupier of a substantial three-storey, state-of-the-art laboratory facility at Charnwood Campus. Recently designated a Life Sciences …See details»
Charnwood Molecular - Products, Competitors, Financials, …
Charnwood Molecular is a contract research organization specializing in integrated drug discovery services within the pharmaceutical and biotechnology sectors. The company offers a suite of …See details»
£54m construction project in Loughborough creates flexible …
Jul 15, 2021 Charnwood Campus has recommissioned its world-class synthetic and chemistry research facility to the highest standard to cater to the needs of its newest occupier and …See details»
Charnwood Molecular unveils plans to quadruple capacity - Synova
Apr 28, 2021 Steve Allin, CEO of Charnwood Molecular, commented: “The truly world-class facilities at Charnwood Campus provide us with a key piece in our strategic plan to become …See details»
Charnwood Molecular has moved to a single site from its previous ...
Apr 26, 2022 Charnwood Molecular said its investment in the site addressed a national need for specialist bio-chemistry facilities to drive potentially life-saving research into new drugs. The …See details»
Nottingham drug discovery and chemistry firm has sights set on ...
Jan 5, 2019 But today, bioscience firm Charnwood Molecular is providing cutting edge medicinal chemistry services for clients across the globe, with drug discovery just one of its areas of …See details»
Nottingham Drug Discovery and Chemistry Firm has Sights set on ...
Feb 18, 2019 But today, bioscience firm Charnwood Molecular is providing cutting edge medicinal chemistry services for clients across the globe, with drug discovery just one of its …See details»
World-class three-storey lab space officially opens after £3.4m ...
May 9, 2022 Project had £3.4m investment from LLEP and Charnwood Borough Council ; Charnwood Molecular will increase productivity while accelerating innovation and growth ; …See details»
CHARNWOOD MOLECULAR UNVEILS SIGNIFICANT EXPANSION …
Apr 23, 2021 Charnwood Molecular, a leading UK-based pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, has unveiled plans for significant …See details»
Combining Discovery Biology with Medicinal Chemistry…One Year …
Jun 16, 2022 In June 2021 Charnwood Molecular was delighted to announce the acquisition of Aurelia Bioscience, an assay development, pharmacological profiling and compound …See details»